Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

[Infliximab].

Goujon C, Bachelez H; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):483-486. doi: 10.1016/j.annder.2019.04.013. Epub 2019 Jun 20. French. No abstract available.

PMID:
31230775
2.

[Methotrexate].

Beylot-Barry M, Le Maitre M, Goujon C; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):459-465. doi: 10.1016/j.annder.2019.04.009. Epub 2019 Jun 14. French. No abstract available.

PMID:
31204126
3.

Author Correction: The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry.

Doyle T, Moncorgé O, Bonaventure B, Pollpeter D, Lussignol M, Tauziet M, Apolonia L, Catanese MT, Goujon C, Malim MH.

Nat Microbiol. 2019 Mar;4(3):539. doi: 10.1038/s41564-019-0366-0.

PMID:
30670794
4.

Methotrexate in atopic eczema. Comments to: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.

Goujon C, Nicolas JF, Nosbaum A.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e154-e155. doi: 10.1111/jdv.15386. Epub 2019 Jan 9. No abstract available.

PMID:
30520142
5.

Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.

Dicks MDJ, Betancor G, Jimenez-Guardeño JM, Pessel-Vivares L, Apolonia L, Goujon C, Malim MH.

PLoS Pathog. 2018 Nov 29;14(11):e1007408. doi: 10.1371/journal.ppat.1007408. eCollection 2018 Nov.

6.

The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry.

Doyle T, Moncorgé O, Bonaventure B, Pollpeter D, Lussignol M, Tauziet M, Apolonia L, Catanese MT, Goujon C, Malim MH.

Nat Microbiol. 2018 Dec;3(12):1369-1376. doi: 10.1038/s41564-018-0273-9. Epub 2018 Nov 26. Erratum in: Nat Microbiol. 2019 Mar;4(3):539.

7.

Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Schilling M, Bulli L, Weigang S, Graf L, Naumann S, Patzina C, Wagner V, Bauersfeld L, Goujon C, Hengel H, Halenius A, Ruzsics Z, Schaller T, Kochs G.

J Virol. 2018 Aug 16;92(17). pii: e01056-18. doi: 10.1128/JVI.01056-18. Print 2018 Sep 1.

8.

Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitis.

Delcasso B, Goujon C, Hacard F, Delcroix F, Grande S, Berard F, Nicolas JF, Nosbaum A.

Eur J Dermatol. 2018 Apr 1;28(2):266-267. doi: 10.1684/ejd.2018.3231. No abstract available.

PMID:
29624179
9.

Safety and efficacy of biological therapies in patients with psoriasis with alcoholic cirrhosis: a French retrospective study of 23 cases.

Begon E, Beneton N, Poiraud C, Droitcourt C, Jacobzone C, Vermersch-Langlin A, Descamps V, Perrot JL, Khemis A, Pallure V, Fougerousse AC, Sigal-Grinberg M, Schmutz JL, Goujon C, Reguiai Z; Groupe d'Etudes Multicentrique GEM RESOPSO.

Br J Dermatol. 2018 Aug;179(2):512-513. doi: 10.1111/bjd.16490. Epub 2018 Jun 21. No abstract available.

PMID:
29480522
10.

High-concentration topical capsaicin in the management of refractory neuropathic pain in patients with neurofibromatosis type 1: a case series.

Bardo-Brouard P, Luizard C, Valeyrie-Allanore L, Goujon C, Do B, Colin A, Wolkenstein P, Paul M.

Curr Med Res Opin. 2018 May;34(5):887-891. doi: 10.1080/03007995.2018.1433142. Epub 2018 Feb 21.

PMID:
29368950
11.

[Xe International Congress of the Société de pathologie exotique, 8-9 November 2017, Haiphong (Vietnam) - Surgery Access in Tropical Areas].

Buisson Y, Guyon P, Buisson Y, Osinki N, Tamames C, Leconte J, Jarry M, Robert J, Dumurgier C, Choua O, Ahmat MO, Moussa KM, Sabe D, Telniaret A, Rabo AM, Kitoko N, Allatombaye B, Bunn D, Hong Dao N, Huy LD, Bich Ngoc HL, Tram LH, Van Khoi T, Van Thuc P, Van Linh P, Kourouma K, Gerald FT, Kourouma K, Saibou PO, Ngunyi GC, Wombe B, Alessandroni P, Andrei R, Delmont J, Gasiglia C, Haï VV, Heng M, Heng T, Khampho C, Mekhalfa D, Marcaggi S, Pimontipa M, Plotton JR, The Ngo NA, Vilayphone T, Duong TX, Hoa NL, Pays JF, Buchy P, Goujon C, Bouchaud O, Consigny PH, de Gentile L, D'Ortenzio E, Gautret P, Sorge F, Strady C, Pichard E, Haddar C, Bégaud E, Yuh MY, Law EL, Germani Y, Bouchaud O, Houze S; groupe d’étude MalaRia, Chandenier J, Jannin J, Solano P, Quick I, Debre P, Guyon P, Ensaf A, Bourée P, Fabre-Teste B, El Mouden M, Soula G.

Bull Soc Pathol Exot. 2017 Dec;110(5):353-354. doi: 10.1007/s13149-017-0586-6. French. No abstract available.

PMID:
29299881
12.

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.

Goujon C, Viguier M, Staumont-Sallé D, Bernier C, Guillet G, Lahfa M, Ferrier Le Bouedec MC, Cambazard F, Bottigioli D, Grande S, Dahel K, Bérard F, Rabilloud M, Mercier C, Nicolas JF.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):562-569.e3. doi: 10.1016/j.jaip.2017.07.007. Epub 2017 Sep 28.

PMID:
28967549
13.

CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.

Goujon C, Gougeon ML, Tondeur L, Poirier B, Seffer V, Desprès P, Consigny PH, Vray M; study group.

Vaccine. 2017 Oct 27;35(45):6166-6171. doi: 10.1016/j.vaccine.2017.09.047. Epub 2017 Sep 25.

PMID:
28958813
14.

Measles virus infection of human keratinocytes: Possible link between measles and atopic dermatitis.

Gourru-Lesimple G, Mathieu C, Thevenet T, Guillaume-Vasselin V, Jégou JF, Boer CG, Tomczak K, Bloyet LM, Giraud C, Grande S, Goujon C, Cornu C, Horvat B.

J Dermatol Sci. 2017 May;86(2):97-105. doi: 10.1016/j.jdermsci.2017.01.015. Epub 2017 Feb 10.

PMID:
28233587
15.

IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.

Bernard M, Carrasco C, Laoubi L, Guiraud B, Rozières A, Goujon C, Duplan H, Bessou-Touya S, Nicolas JF, Vocanson M, Galliano MF.

J Pathol. 2017 Jun;242(2):234-245. doi: 10.1002/path.4887. Epub 2017 Apr 6.

PMID:
28191908
16.

Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.

Bulli L, Apolonia L, Kutzner J, Pollpeter D, Goujon C, Herold N, Schwarz SM, Giernat Y, Keppler OT, Malim MH, Schaller T.

J Virol. 2016 Jul 27;90(16):7469-7480. doi: 10.1128/JVI.00458-16. Print 2016 Aug 15.

17.

Analgesic effects of navigated motor cortex rTMS in patients with chronic neuropathic pain.

Ayache SS, Ahdab R, Chalah MA, Farhat WH, Mylius V, Goujon C, Sorel M, Lefaucheur JP.

Eur J Pain. 2016 Oct;20(9):1413-22. doi: 10.1002/ejp.864. Epub 2016 Apr 7.

PMID:
27061948
18.

Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development.

Kirsten N, Bulai Livideanu C, Richard MA, Konstantinou MP, Khemis A, Balluteaud C, Goujon C, Beylot-Barry M, Paul C; French Psoriasis Research Group.

Br J Dermatol. 2016 Sep;175(3):636-8. doi: 10.1111/bjd.14622. Epub 2016 Jul 5. No abstract available.

PMID:
27038074
19.

Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.

Dicks MD, Goujon C, Pollpeter D, Betancor G, Apolonia L, Bergeron JR, Malim MH.

J Virol. 2015 Oct 7;90(1):22-32. doi: 10.1128/JVI.02247-15. Print 2016 Jan 1.

20.

Characterization of Pain in Familial Amyloid Polyneuropathy.

Ng Wing Tin S, Planté-Bordeneuve V, Salhi H, Goujon C, Damy T, Lefaucheur JP.

J Pain. 2015 Nov;16(11):1106-14. doi: 10.1016/j.jpain.2015.07.010. Epub 2015 Aug 18.

PMID:
26291275
21.

[Current immunizations for travelers].

Goujon C.

Rev Prat. 2015 Apr;65(4):479-83. French. Erratum in: Rev Prat. 2015 May;65(5):617. Dosage error in article text.

PMID:
26058189
22.

HIV-1 and interferons: who's interfering with whom?

Doyle T, Goujon C, Malim MH.

Nat Rev Microbiol. 2015 Jul;13(7):403-13. doi: 10.1038/nrmicro3449. Epub 2015 Apr 27. Review.

PMID:
25915633
23.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
24.

UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin.

Achachi A, Vocanson M, Bastien P, Péguet-Navarro J, Grande S, Goujon C, Breton L, Castiel-Higounenc I, Nicolas JF, Gueniche A.

J Invest Dermatol. 2015 Aug;135(8):2058-2067. doi: 10.1038/jid.2015.118. Epub 2015 Mar 25.

25.

A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2.

Goujon C, Greenbury RA, Papaioannou S, Doyle T, Malim MH.

J Virol. 2015 Apr;89(8):4676-80. doi: 10.1128/JVI.00169-15. Epub 2015 Feb 11.

26.

[Histaminergic angioedema and chronic urticaria].

Hacard F, Nosbaum A, Bensaid B, Nicolas JF, Augey F, Goujon C, Bérard F.

Presse Med. 2015 Jan;44(1):37-42. doi: 10.1016/j.lpm.2014.11.001. Epub 2014 Dec 18. Review. French.

PMID:
25535159
27.

Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults.

Nougarede N, Bisceglia H, Rozières A, Goujon C, Boudet F, Laurent P, Vanbervliet B, Rodet K, Hennino A, Nicolas JF.

Hum Vaccin Immunother. 2014;10(9):2713-20. doi: 10.4161/hv.29695.

28.

Hepatitis B screening in travelers: a retrospective analysis.

Gergely A, Bechet S, Goujon C, Benabdelmoumen G, Consigny PH.

Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):707-12. doi: 10.1016/j.tmaid.2014.07.003. Epub 2014 Jul 17.

PMID:
25086491
29.

Spinal stimulation for movement disorders.

Thiriez C, Gurruchaga JM, Goujon C, Fénelon G, Palfi S.

Neurotherapeutics. 2014 Jul;11(3):543-52. Review.

30.

Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.

Goujon C, Moncorgé O, Bauby H, Doyle T, Barclay WS, Malim MH.

J Virol. 2014 Aug;88(16):9017-26. doi: 10.1128/JVI.01269-14. Epub 2014 Jun 4.

31.

New insights into an X-traordinary viral protein.

Schaller T, Bauby H, Hué S, Malim MH, Goujon C.

Front Microbiol. 2014 Apr 8;5:126. doi: 10.3389/fmicb.2014.00126. eCollection 2014. Review.

32.
33.

[Human MX2 is an effector of IFN-mediated resistance to HIV-1 infection].

Goujon C.

Med Sci (Paris). 2014 Mar;30(3):233-5. doi: 10.1051/medsci/20143003004. Epub 2014 Mar 31. French. No abstract available.

34.

Jahn-Teller, polarity, and insulator-to-metal transition in BiMnO3 at high pressure.

Guennou M, Bouvier P, Toulemonde P, Darie C, Goujon C, Bordet P, Hanfland M, Kreisel J.

Phys Rev Lett. 2014 Feb 21;112(7):075501. Epub 2014 Feb 19.

PMID:
24579610
35.

Sensory correlates of pain in peripheral neuropathies.

Ng Wing Tin S, Ciampi de Andrade D, Goujon C, Planté-Bordeneuve V, Créange A, Lefaucheur JP.

Clin Neurophysiol. 2014 May;125(5):1048-58. doi: 10.1016/j.clinph.2013.09.038. Epub 2013 Oct 28.

PMID:
24176295
36.

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.

Goujon C, Moncorgé O, Bauby H, Doyle T, Ward CC, Schaller T, Hué S, Barclay WS, Schulz R, Malim MH.

Nature. 2013 Oct 24;502(7472):559-62. doi: 10.1038/nature12542. Epub 2013 Sep 18.

37.

Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection.

Goujon C, Schaller T, Galão RP, Amie SM, Kim B, Olivieri K, Neil SJ, Malim MH.

Retrovirology. 2013 Feb 25;10:23. doi: 10.1186/1742-4690-10-23.

38.

Sensitizing curium luminescence through an antenna protein to investigate biological actinide transport mechanisms.

Sturzbecher-Hoehne M, Goujon C, Deblonde GJ, Mason AB, Abergel RJ.

J Am Chem Soc. 2013 Feb 20;135(7):2676-83. doi: 10.1021/ja310957f. Epub 2013 Feb 11.

39.

Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.

Viguier M, Aubin F, Delaporte E, Pagès C, Paul C, Beylot-Barry M, Goujon C, Rybojad M, Bachelez H; Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie.

Arch Dermatol. 2012 Dec;148(12):1423-5. doi: 10.1001/2013.jamadermatol.80. No abstract available.

PMID:
23247492
40.

Blocking T helper 1/T helper 17 pathways has no effect on patch testing.

Nosbaum A, Rozieres A, Balme B, Goujon C, Nicolas JF, Bérard F.

Contact Dermatitis. 2013 Jan;68(1):58-9. doi: 10.1111/j.1600-0536.2012.02155.x. No abstract available.

PMID:
23227870
41.

Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis.

de Masson A, Ben Said B, Parier J, Begon E, Augey F, Goujon C, Dahel K, Nicolas JF, Bérard F, Bachelez H, Bagot M, Bouaziz JD.

J Am Acad Dermatol. 2012 Dec;67(6):e280-2. doi: 10.1016/j.jaad.2012.05.042. No abstract available.

PMID:
23158640
42.

Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.

Goujon C, Nosbaum A, Bensaid B, Rozières A, Nicolas JF, Bérard F.

Eur J Dermatol. 2012 Sep-Oct;22(5):701-2. doi: 10.1684/ejd.2012.1812. No abstract available.

PMID:
23032063
43.

Analgesic effects of repetitive transcranial magnetic stimulation of the motor cortex in neuropathic pain: influence of theta burst stimulation priming.

Lefaucheur JP, Ayache SS, Sorel M, Farhat WH, Zouari HG, Ciampi de Andrade D, Ahdab R, Ménard-Lefaucheur I, Brugières P, Goujon C.

Eur J Pain. 2012 Nov;16(10):1403-13. doi: 10.1002/j.1532-2149.2012.00150.x. Epub 2012 Apr 16.

PMID:
22508405
44.

AIDS/HIV. HIV interplay with SAMHD1.

Schaller T, Goujon C, Malim MH.

Science. 2012 Mar 16;335(6074):1313-4. doi: 10.1126/science.1221057. No abstract available.

PMID:
22422971
45.

[Infliximab].

Goujon C, Bachelez H.

Ann Dermatol Venereol. 2011 Dec;138(12):839-41. doi: 10.1016/j.annder.2011.10.005. Epub 2011 Nov 5. French. No abstract available.

PMID:
22137623
46.

Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.

Koning FA, Goujon C, Bauby H, Malim MH.

J Virol. 2011 Dec;85(24):13448-52. doi: 10.1128/JVI.00775-11. Epub 2011 Sep 28.

47.

Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease.

Fénelon G, Goujon C, Gurruchaga JM, Cesaro P, Jarraya B, Palfi S, Lefaucheur JP.

Parkinsonism Relat Disord. 2012 Feb;18(2):213-4. doi: 10.1016/j.parkreldis.2011.07.015. Epub 2011 Aug 23. No abstract available.

PMID:
21865071
48.

Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children.

Ploin D, Schwarzenbach F, Dubray C, Nicolas JF, Goujon C, Trong MD, Laurent PE.

Vaccine. 2011 Oct 26;29(46):8438-42. doi: 10.1016/j.vaccine.2011.07.111. Epub 2011 Aug 5.

PMID:
21821081
49.

Predictive value of rTMS in the identification of responders to epidural motor cortex stimulation therapy for pain.

Lefaucheur JP, Ménard-Lefaucheur I, Goujon C, Keravel Y, Nguyen JP.

J Pain. 2011 Oct;12(10):1102-11. doi: 10.1016/j.jpain.2011.05.004. Epub 2011 Jul 31.

PMID:
21807565
50.

A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors.

Berger G, Durand S, Goujon C, Nguyen XN, Cordeil S, Darlix JL, Cimarelli A.

Nat Protoc. 2011 Jun;6(6):806-16. doi: 10.1038/nprot.2011.327. Epub 2011 May 19.

PMID:
21637200

Supplemental Content

Loading ...
Support Center